In addition to counteracting the tumor-killing effect, an increase in immune suppression due to the lack of PD-1 signal transduction in Tregs may also lead to tumor progression similar to hyper-progressive disease [108], a severe cancer condition characterized by rapid tumor growth after immunotherapy [174–176]. Here, PDCD1 is linked to cancer.